Related Experiment Video
Updated: Jan 10, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Integrin αvβ3 as a Non-Genomic Estrogen Receptor in Breast Cancer for Signaling Pathways and Crosstalk
Kuan Wang1, Zi-Lin Li1,2, Lin-Yi Huang3
1Graduate Institute of Nanomedicine and Medical Engineering, College of Medical Engineering, Taipei Medical University, Taipei 11031, Taiwan.
Integrin αvβ3, a hormone receptor, collaborates with estrogen receptors (ER-α) and GPER in non-genomic pathways, influencing cancer growth and metastasis. This interaction highlights integrin αvβ3 as a potential therapeutic target for hormone-driven cancers.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Integrin αvβ3 is crucial for cell functions and uniquely expressed in cancer cells, suggesting a role in tumor progression.
- Estrogen signaling occurs through genomic and non-genomic pathways, with non-genomic actions involving G protein-coupled estrogen receptor 1 (GPER).
Purpose of the Study:
- To investigate the non-genomic roles of Integrin αvβ3 in collaboration with estrogen receptors (ER-α) and GPER in cancer biology.
- To elucidate the molecular mechanisms underlying these non-genomic functions.
Main Methods:
- Analysis of signal transduction pathways including focal activated kinase (FAK), mitogen-activated protein kinase (ERK1/2), and phosphatidylinositol 3-kinase (PI3K).
- Examination of differential gene expression related to cellular processes in cancer.
Main Results:
- Integrin αvβ3, ER-α, and GPER cooperate in non-genomic signaling pathways that promote estrogen-induced cancer growth.
- These interactions involve key signal transduction molecules (FAK, ERK1/2, PI3K) and affect multiple cancer-related genes.
Conclusions:
- Integrin αvβ3 acts as a hormone receptor, mediating non-genomic estrogen effects crucial for cancer progression.
- The interplay between Integrin αvβ3, ER-α, and GPER presents a novel therapeutic strategy for targeting hormone-dependent cancers.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
Endocrine Signaling

